Clinical Oncology
Volume 19, Issue 8 , Pages 572-576, October 2007

Experience of the Use of Trabectedin (ET-743, Yondelis™) in 21 Patients with Pre-treated Advanced Sarcoma from a Single Centre

  • R. Roylance

      Affiliations

    • The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, London NW1 2PG, UK
    • Cancer Research UK Molecular Oncology Unit, Barts and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
  • ,
  • B. Seddon

      Affiliations

    • The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, London NW1 2PG, UK
    • Corresponding Author InformationAuthor for correspondence: B. Seddon, The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, 250 Euston Road, London NW1 2PG, UK.
  • ,
  • A. McTiernan

      Affiliations

    • The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, London NW1 2PG, UK
  • ,
  • K. Sykes

      Affiliations

    • The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, London NW1 2PG, UK
  • ,
  • S. Daniels

      Affiliations

    • The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, London NW1 2PG, UK
  • ,
  • J. Whelan

      Affiliations

    • The London Bone and Soft Tissue Tumour Service, Department of Oncology, University College Hospital, London NW1 2PG, UK

Received 6 November 2006; received in revised form 8 May 2007; accepted 16 May 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(07)00646-2

doi:10.1016/j.clon.2007.05.006

Clinical Oncology
Volume 19, Issue 8 , Pages 572-576, October 2007